rs17769217

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000645861.1(EMICERI):​n.8231C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 132,914 control chromosomes in the GnomAD database, including 883 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 883 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

EMICERI
ENST00000645861.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.24

Publications

3 publications found
Variant links:
Genes affected
EMICERI (HGNC:53656): (EQTN MOB3B IFNK C9orf72 enhancer RNA I)
C9orf72 (HGNC:28337): (C9orf72-SMCR8 complex subunit) The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2016]
C9orf72 Gene-Disease associations (from GenCC):
  • frontotemporal dementia and/or amyotrophic lateral sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000645861.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EMICERI
ENST00000645861.1
n.8231C>G
non_coding_transcript_exon
Exon 2 of 2
C9orf72
ENST00000673600.1
n.*267+4582G>C
intron
N/AENSP00000500650.1

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
14608
AN:
132820
Hom.:
883
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0444
Gnomad AMI
AF:
0.200
Gnomad AMR
AF:
0.0998
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.000990
Gnomad SAS
AF:
0.0910
Gnomad FIN
AF:
0.217
Gnomad MID
AF:
0.113
Gnomad NFE
AF:
0.139
Gnomad OTH
AF:
0.120
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
2
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.110
AC:
14606
AN:
132914
Hom.:
883
Cov.:
33
AF XY:
0.113
AC XY:
7222
AN XY:
64104
show subpopulations
African (AFR)
AF:
0.0444
AC:
1534
AN:
34568
American (AMR)
AF:
0.0996
AC:
1223
AN:
12278
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
335
AN:
3230
East Asian (EAS)
AF:
0.000744
AC:
3
AN:
4032
South Asian (SAS)
AF:
0.0909
AC:
326
AN:
3588
European-Finnish (FIN)
AF:
0.217
AC:
1945
AN:
8982
Middle Eastern (MID)
AF:
0.112
AC:
31
AN:
278
European-Non Finnish (NFE)
AF:
0.139
AC:
8828
AN:
63342
Other (OTH)
AF:
0.119
AC:
209
AN:
1758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
671
1341
2012
2682
3353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0565
Hom.:
57
Bravo
AF:
0.0872

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.5
DANN
Benign
0.69
PhyloP100
-2.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17769217; hg19: chr9-27543531; API